… is low (<1 g), the fracture risk is much lower than that … the Danish National Patient Registry
and the Danish National … the excess risk of high-dose TCS use on GIOP and fractures persists …

… fracture incidence in patients exposed to oral glucocorticoids and to analyse the impact of
glucocorticoid use on fracture … , older age, higher initial and cumulative GC dose, GC dose-…

… or hip, but the effect on osteoporotic fractures is not yet clear. … The increased fracture risk
with high-dose oral GCs was … diseases including RA and Danish patients from the general …

… In addition, we performed analyses limited to people of Danish origin. Furthermore, we …
prolonged, high-dose systemic corticosteroid use causes bone loss and increased fracture risk, …

… Studies from France, the United Kingdom, and Denmark have … mg daily, increased with
increasing cumulative exposure, and … of fracture risk and vulnerability to medication side effects. …

… among concomitant users of both PPIs and high-dose oral … the effects of simultaneous use
of both drugs on fracture risk in … of GCs and PPIs was stratified by cumulative GC use and then …

… , high-dose glucocorticoids may result in less fracture risk when … fracture risk (67) although
RCTs alone show no clear effect on BMD (68). High-dose cumulative corticosteroid exposure …

… to an underestimation of the effect of GC on fracture risk in higher daily dose groups, resulting
in a reduced significance of the overall association. The potential effects of confounding by …

… study of patients receiving high-dose glucocorticoids for the … , and includes data on an
accumulated 32 million patients of all … Quantifying the consequences of non-compliance to …

… fracture risk (MOF) in myasthenia gravis patients. To assess this risk, we performed a case–control
study including all Danish … long-term high-dose oral GC use and MOF risk among MG …